Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria

ClinicalTrials.gov ID: NCT05936567

Public ClinicalTrials.gov record NCT05936567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 3:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy, and Safety Study of Povorcitinib in Participants With Chronic Spontaneous Urticaria

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to evaluate the efficacy and safety of povorcitinib in adults with CSU that is inadequately controlled using SOC treatments.

Study identification

NCT ID
NCT05936567
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Incyte Corporation
Industry
Enrollment
136 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2023 (Actual)
Primary completion
Feb 28, 2025 (Actual)
Completion
Oct 9, 2025 (Actual)
Last update posted
Mar 12, 2026

2023 – 2025

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
Clinical Research Center of Alabama Birmingham Alabama 35209 —
Cahaba Dermatology Birmingham Alabama 35244 —
Foothills Research Center Scottsdale Arizona 85260 —
Little Rock Allergy Asthma, Pa Clinical Research Center Lraac Little Rock Arkansas 72205 —
Arkansas Research Trials North Little Rock Arkansas 72117 —
First Oc Dermatology Fountain Valley California 92708 —
Newport Native Md Newport Beach California 92663 —
Antelope Valley Clinical Trials Lancaster Office Palmdale California 93551 —
Allergy and Asthma Consultants, Pc Redwood City California 94063 —
Treasure Valley Medical Research Boise Idaho 83706 —
Midwest Allergy Sinus Asthma, Sc Normal Illinois 61761 —
Delricht Research New Orleans Louisiana 70115 —
David Fivenson, Md, Dermatology, Pllc Ann Arbor Michigan 48103 —
Revival Research Institute, Llc Troy Troy Michigan 48084 —
The Clinical Research Center Crc, Llc St Louis Missouri 63141 —
Optimed Research Ltd Columbus Ohio 43235 —
Central Sooner Research Oklahoma City Oklahoma 73170 —
Vital Prospects Clinical Research Institute, Pc Vpcri Tulsa Oklahoma 74136 —
Dermdox Center For Dermatology Sugarloaf Pennsylvania 18249 —
Allergy and Asthma Center of Charleston Charleston South Carolina 29407 —
Rainey and Finklea Dermatology San Antonio Texas 78212 —
Bellingham Asthma, Allergy Immunology Clinic Bellingham Washington 98225 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05936567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05936567 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →